ArticleChinese medical journal2019

First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China.

Xue-Ru Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.